RNAi for Therapeutic Market - Global Outlook and Forecast 2021-2027

RNAi for Therapeutic Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 RNAi for Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNAi for Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNAi for Therapeutic Overall Market Size
2.1 Global RNAi for Therapeutic Market Size: 2021 VS 2027
2.2 Global RNAi for Therapeutic Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNAi for Therapeutic Players in Global Market
3.2 Top Global RNAi for Therapeutic Companies Ranked by Revenue
3.3 Global RNAi for Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 RNAi for Therapeutic Companies in Global Market, by Revenue in 2020
3.5 Global Companies RNAi for Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNAi for Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 RNAi for Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 RNAi for Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global RNAi for Therapeutic Market Size Markets, 2021 & 2027
4.1.2 siRNA
4.1.3 miRNA
4.1.4 shRNA
4.2 By Type - Global RNAi for Therapeutic Revenue & Forecasts
4.2.1 By Type - Global RNAi for Therapeutic Revenue, 2016-2021
4.2.2 By Type - Global RNAi for Therapeutic Revenue, 2022-2027
4.2.3 By Type - Global RNAi for Therapeutic Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNAi for Therapeutic Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Cardiovascular
5.1.4 HBV
5.1.5 Others
5.2 By Application - Global RNAi for Therapeutic Revenue & Forecasts
5.2.1 By Application - Global RNAi for Therapeutic Revenue, 2016-2021
5.2.2 By Application - Global RNAi for Therapeutic Revenue, 2022-2027
5.2.3 By Application - Global RNAi for Therapeutic Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global RNAi for Therapeutic Market Size, 2021 & 2027
6.2 By Region - Global RNAi for Therapeutic Revenue & Forecasts
6.2.1 By Region - Global RNAi for Therapeutic Revenue, 2016-2021
6.2.2 By Region - Global RNAi for Therapeutic Revenue, 2022-2027
6.2.3 By Region - Global RNAi for Therapeutic Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America RNAi for Therapeutic Revenue, 2016-2027
6.3.2 US RNAi for Therapeutic Market Size, 2016-2027
6.3.3 Canada RNAi for Therapeutic Market Size, 2016-2027
6.3.4 Mexico RNAi for Therapeutic Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe RNAi for Therapeutic Revenue, 2016-2027
6.4.2 Germany RNAi for Therapeutic Market Size, 2016-2027
6.4.3 France RNAi for Therapeutic Market Size, 2016-2027
6.4.4 U.K. RNAi for Therapeutic Market Size, 2016-2027
6.4.5 Italy RNAi for Therapeutic Market Size, 2016-2027
6.4.6 Russia RNAi for Therapeutic Market Size, 2016-2027
6.4.7 Nordic Countries RNAi for Therapeutic Market Size, 2016-2027
6.4.8 Benelux RNAi for Therapeutic Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia RNAi for Therapeutic Revenue, 2016-2027
6.5.2 China RNAi for Therapeutic Market Size, 2016-2027
6.5.3 Japan RNAi for Therapeutic Market Size, 2016-2027
6.5.4 South Korea RNAi for Therapeutic Market Size, 2016-2027
6.5.5 Southeast Asia RNAi for Therapeutic Market Size, 2016-2027
6.5.6 India RNAi for Therapeutic Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America RNAi for Therapeutic Revenue, 2016-2027
6.6.2 Brazil RNAi for Therapeutic Market Size, 2016-2027
6.6.3 Argentina RNAi for Therapeutic Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNAi for Therapeutic Revenue, 2016-2027
6.7.2 Turkey RNAi for Therapeutic Market Size, 2016-2027
6.7.3 Israel RNAi for Therapeutic Market Size, 2016-2027
6.7.4 Saudi Arabia RNAi for Therapeutic Market Size, 2016-2027
6.7.5 UAE RNAi for Therapeutic Market Size, 2016-2027
7 Players Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Corporate Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.1.4 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue in Global (2016-2021)
7.1.5 Alnylam Pharmaceuticals Key News
7.2 Arbutus Biopharma (Tekmira)
7.2.1 Arbutus Biopharma (Tekmira) Corporate Summary
7.2.2 Arbutus Biopharma (Tekmira) Business Overview
7.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Major Product Offerings
7.2.4 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue in Global (2016-2021)
7.2.5 Arbutus Biopharma (Tekmira) Key News
7.3 Arrowhead
7.3.1 Arrowhead Corporate Summary
7.3.2 Arrowhead Business Overview
7.3.3 Arrowhead RNAi for Therapeutic Major Product Offerings
7.3.4 Arrowhead RNAi for Therapeutic Revenue in Global (2016-2021)
7.3.5 Arrowhead Key News
7.4 Dicerna Pharmaceuticals
7.4.1 Dicerna Pharmaceuticals Corporate Summary
7.4.2 Dicerna Pharmaceuticals Business Overview
7.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.4.4 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue in Global (2016-2021)
7.4.5 Dicerna Pharmaceuticals Key News
7.5 Mirna Therapeutics
7.5.1 Mirna Therapeutics Corporate Summary
7.5.2 Mirna Therapeutics Business Overview
7.5.3 Mirna Therapeutics RNAi for Therapeutic Major Product Offerings
7.5.4 Mirna Therapeutics RNAi for Therapeutic Revenue in Global (2016-2021)
7.5.5 Mirna Therapeutics Key News
7.6 Quark Pharmaceuticals
7.6.1 Quark Pharmaceuticals Corporate Summary
7.6.2 Quark Pharmaceuticals Business Overview
7.6.3 Quark Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.6.4 Quark Pharmaceuticals RNAi for Therapeutic Revenue in Global (2016-2021)
7.6.5 Quark Pharmaceuticals Key News
7.7 RXi Pharmaceuticals
7.7.1 RXi Pharmaceuticals Corporate Summary
7.7.2 RXi Pharmaceuticals Business Overview
7.7.3 RXi Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.4.4 RXi Pharmaceuticals RNAi for Therapeutic Revenue in Global (2016-2021)
7.7.5 RXi Pharmaceuticals Key News
7.8 Silence Therapeutics
7.8.1 Silence Therapeutics Corporate Summary
7.8.2 Silence Therapeutics Business Overview
7.8.3 Silence Therapeutics RNAi for Therapeutic Major Product Offerings
7.8.4 Silence Therapeutics RNAi for Therapeutic Revenue in Global (2016-2021)
7.8.5 Silence Therapeutics Key News
7.9 Benitec Biopharma
7.9.1 Benitec Biopharma Corporate Summary
7.9.2 Benitec Biopharma Business Overview
7.9.3 Benitec Biopharma RNAi for Therapeutic Major Product Offerings
7.9.4 Benitec Biopharma RNAi for Therapeutic Revenue in Global (2016-2021)
7.9.5 Benitec Biopharma Key News
7.10 miRagen Therapeutics
7.10.1 miRagen Therapeutics Corporate Summary
7.10.2 miRagen Therapeutics Business Overview
7.10.3 miRagen Therapeutics RNAi for Therapeutic Major Product Offerings
7.10.4 miRagen Therapeutics RNAi for Therapeutic Revenue in Global (2016-2021)
7.10.5 miRagen Therapeutics Key News
7.11 Sylentis
7.11.1 Sylentis Corporate Summary
7.11.2 Sylentis Business Overview
7.11.3 Sylentis RNAi for Therapeutic Major Product Offerings
7.11.4 Sylentis RNAi for Therapeutic Revenue in Global (2016-2021)
7.11.5 Sylentis Key News
7.12 Gradalis
7.12.1 Gradalis Corporate Summary
7.12.2 Gradalis Business Overview
7.12.3 Gradalis RNAi for Therapeutic Major Product Offerings
7.12.4 Gradalis RNAi for Therapeutic Revenue in Global (2016-2021)
7.12.5 Gradalis Key News
7.13 Sirnaomics
7.13.1 Sirnaomics Corporate Summary
7.13.2 Sirnaomics Business Overview
7.13.3 Sirnaomics RNAi for Therapeutic Major Product Offerings
7.13.4 Sirnaomics RNAi for Therapeutic Revenue in Global (2016-2021)
7.13.5 Sirnaomics Key News
7.14 Silenseed
7.14.1 Silenseed Corporate Summary
7.14.2 Silenseed Business Overview
7.14.3 Silenseed RNAi for Therapeutic Major Product Offerings
7.14.4 Silenseed RNAi for Therapeutic Revenue in Global (2016-2021)
7.14.5 Silenseed Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. RNAi for Therapeutic Market Opportunities & Trends in Global Market
Table 2. RNAi for Therapeutic Market Drivers in Global Market
Table 3. RNAi for Therapeutic Market Restraints in Global Market
Table 4. Key Players of RNAi for Therapeutic in Global Market
Table 5. Top RNAi for Therapeutic Players in Global Market, Ranking by Revenue (2019)
Table 6. Global RNAi for Therapeutic Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global RNAi for Therapeutic Revenue Share by Companies, 2016-2021
Table 8. Global Companies RNAi for Therapeutic Product Type
Table 9. List of Global Tier 1 RNAi for Therapeutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNAi for Therapeutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global RNAi for Therapeutic Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - RNAi for Therapeutic Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - RNAi for Therapeutic Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global RNAi for Therapeutic Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - RNAi for Therapeutic Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - RNAi for Therapeutic Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global RNAi for Therapeutic Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global RNAi for Therapeutic Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global RNAi for Therapeutic Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America RNAi for Therapeutic Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America RNAi for Therapeutic Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe RNAi for Therapeutic Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe RNAi for Therapeutic Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia RNAi for Therapeutic Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia RNAi for Therapeutic Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America RNAi for Therapeutic Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America RNAi for Therapeutic Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa RNAi for Therapeutic Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa RNAi for Therapeutic Revenue, (US$, Mn), 2022-2027
Table 30. Alnylam Pharmaceuticals Corporate Summary
Table 31. Alnylam Pharmaceuticals RNAi for Therapeutic Product Offerings
Table 32. Alnylam Pharmaceuticals RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 33. Arbutus Biopharma (Tekmira) Corporate Summary
Table 34. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Offerings
Table 35. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 36. Arrowhead Corporate Summary
Table 37. Arrowhead RNAi for Therapeutic Product Offerings
Table 38. Arrowhead RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 39. Dicerna Pharmaceuticals Corporate Summary
Table 40. Dicerna Pharmaceuticals RNAi for Therapeutic Product Offerings
Table 41. Dicerna Pharmaceuticals RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 42. Mirna Therapeutics Corporate Summary
Table 43. Mirna Therapeutics RNAi for Therapeutic Product Offerings
Table 44. Mirna Therapeutics RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 45. Quark Pharmaceuticals Corporate Summary
Table 46. Quark Pharmaceuticals RNAi for Therapeutic Product Offerings
Table 47. Quark Pharmaceuticals RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 48. RXi Pharmaceuticals Corporate Summary
Table 49. RXi Pharmaceuticals RNAi for Therapeutic Product Offerings
Table 50. RXi Pharmaceuticals RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 51. Silence Therapeutics Corporate Summary
Table 52. Silence Therapeutics RNAi for Therapeutic Product Offerings
Table 53. Silence Therapeutics RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 54. Benitec Biopharma Corporate Summary
Table 55. Benitec Biopharma RNAi for Therapeutic Product Offerings
Table 56. Benitec Biopharma RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 57. miRagen Therapeutics Corporate Summary
Table 58. miRagen Therapeutics RNAi for Therapeutic Product Offerings
Table 59. miRagen Therapeutics RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 60. Sylentis Corporate Summary
Table 61. Sylentis RNAi for Therapeutic Product Offerings
Table 62. Sylentis RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 63. Gradalis Corporate Summary
Table 64. Gradalis RNAi for Therapeutic Product Offerings
Table 65. Gradalis RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 66. Sirnaomics Corporate Summary
Table 67. Sirnaomics RNAi for Therapeutic Product Offerings
Table 68. Sirnaomics RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
Table 69. Silenseed Corporate Summary
Table 70. Silenseed RNAi for Therapeutic Product Offerings
Table 71. Silenseed RNAi for Therapeutic Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. RNAi for Therapeutic Segment by Type
Figure 2. RNAi for Therapeutic Segment by Application
Figure 3. Global RNAi for Therapeutic Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global RNAi for Therapeutic Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global RNAi for Therapeutic Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by RNAi for Therapeutic Revenue in 2020
Figure 8. By Type - Global RNAi for Therapeutic Revenue Market Share, 2016-2027
Figure 9. By Application - Global RNAi for Therapeutic Revenue Market Share, 2016-2027
Figure 10. By Region - Global RNAi for Therapeutic Revenue Market Share, 2016-2027
Figure 11. By Country - North America RNAi for Therapeutic Revenue Market Share, 2016-2027
Figure 12. US RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 13. Canada RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe RNAi for Therapeutic Revenue Market Share, 2016-2027
Figure 16. Germany RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 17. France RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 19. Italy RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 20. Russia RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia RNAi for Therapeutic Revenue Market Share, 2016-2027
Figure 24. China RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 25. Japan RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 28. India RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America RNAi for Therapeutic Revenue Market Share, 2016-2027
Figure 30. Brazil RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa RNAi for Therapeutic Revenue Market Share, 2016-2027
Figure 33. Turkey RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 34. Israel RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 36. UAE RNAi for Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 37. Alnylam Pharmaceuticals RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Arrowhead RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Dicerna Pharmaceuticals RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Mirna Therapeutics RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Quark Pharmaceuticals RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. RXi Pharmaceuticals RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Silence Therapeutics RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Benitec Biopharma RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. miRagen Therapeutics RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Sylentis RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Gradalis RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Sirnaomics RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Targeted RNA Sequencing Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 71

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types. In The report, we ......

Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87

According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period. The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......

Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 94

According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......

Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 133

Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......

Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101

Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......

Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028

Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 137

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028

Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 100

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global RNAi for Therapeutic Market Status and Outlook 2023-2028

Published: 08-Nov-2023        Price: US 3160 Onwards        Pages: 106

RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 104

Market Overview of Global RNAi for Therapeutic market: According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years. RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs